ZOLADEX (AstraZeneca Pty Ltd)
Product name
ZOLADEX
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
63 (175 working days)
Active ingredients
Goserelin
Registration type
EOI
Indication
Breast cancer
Management of oestrogen-receptor (ER) positive early and advanced breast cancer in pre and peri menopausal women.